FDA Provides Framework for Biomarker Selection in Finalized DDT Guidance

Drug Industry Daily
A A
The FDA is encouraging drugmakers to work together to get agency qualification for drug development tools (DDTs), which can then be used to aid in development and review of multiple companies’ drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily